blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1482967

EP1482967 - PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING PLGF-1 [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.03.2014
Database last updated on 22.01.2025
Most recent event   Tooltip21.03.2014No opposition filed within time limitpublished on 23.04.2014  [2014/17]
Applicant(s)For all designated states
GEYMONAT S.p.A.
2 Via S.Anna
I-03012 Anagni FR / IT
[2004/50]
Inventor(s)01 / MAGLIONE, Domenico
Via della Peschiera, 20
I-03012 Anagni / IT
02 / BATTISTI, Mauro
Viale degli Eroi, 16
I-00032 Carpineto / IT
03 / CONTI, Ettore
Via Toscana, 1 Res. "Colli del Vivaro"
I-00040 Rocca di Papa / IT
04 / SALVIA, Giuseppe
Via Andrea Doria, 39
I-95123 Catania / IT
05 / TUCCI, Marina
Via Sanità, 40
I-03012 Anagni / IT
 [2004/50]
Representative(s)Germinario, Claudio, et al
Società Italiana Brevetti S.p.A.
Piazza di Pietra, 38-39
00186 Roma / IT
[N/P]
Former [2013/20]Germinario, Claudio, et al
Società Italiana Brevetti S.p.A. Piazza di Pietra, 38-39
00186 Roma / IT
Former [2004/50]Germinario, Claudio, et al
Società Italiana Brevetti S.p.A. Piazza di Pietra 39
00186 Roma / IT
Application number, filing date03712652.105.03.2003
[2004/50]
WO2003IT00132
Priority number, dateIT2002RM0011905.03.2002         Original published format: IT RM20020119
[2004/50]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03074075
Date:12.09.2003
Language:EN
[2003/37]
Type: A1 Application with search report 
No.:EP1482967
Date:08.12.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 12.09.2003 takes the place of the publication of the European patent application.
[2004/50]
Type: B1 Patent specification 
No.:EP1482967
Date:15.05.2013
Language:EN
[2013/20]
Search report(s)International search report - published on:EP12.09.2003
ClassificationIPC:A61K8/64, A61Q7/00, A61Q19/08, A61K38/18, A61P17/02, A61P17/14
[2012/35]
CPC:
A61Q7/00 (EP,US); A61K38/18 (KR); A61K38/1866 (EP,US);
A61K8/64 (EP,US); A61P17/00 (EP); A61P17/02 (EP);
A61P17/14 (EP); A61P19/02 (EP); A61P19/04 (EP);
A61P21/00 (EP); A61P43/00 (EP); A61P5/00 (EP);
A61P9/14 (EP); A61Q19/08 (EP,US) (-)
Former IPC [2004/50]A61K38/18, A61K7/48, A61P17/00, A61P17/02, A61P17/14
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2004/50]
Extension statesAL26.08.2004
LT26.08.2004
LV26.08.2004
MK26.08.2004
TitleGerman:PHARMAZEUTISCHE UND KOSMETISCHE ZUSAMMENSETZUNGEN ENHALTEND PLGF-1[2004/50]
English:PHARMACEUTICAL AND COSMETIC COMPOSITIONS COMPRISING PLGF-1[2004/50]
French:COMPOSITIONS PHARMACEUTIQUES ET COSMETIQUES RENFERMANT LE FACTEUR DE CROISSANCE PLACENTAIRE (PLGF)[2004/50]
Entry into regional phase26.08.2004National basic fee paid 
26.08.2004Designation fee(s) paid 
26.08.2004Examination fee paid 
Examination procedure06.10.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
26.08.2004Examination requested  [2004/50]
05.03.2007Despatch of a communication from the examining division (Time limit: M06)
13.09.2007Reply to a communication from the examining division
22.07.2010Despatch of a communication from the examining division (Time limit: M06)
25.01.2011Reply to a communication from the examining division
29.12.2011Despatch of a communication from the examining division (Time limit: M06)
26.06.2012Reply to a communication from the examining division
19.10.2012Communication of intention to grant the patent
28.02.2013Fee for grant paid
28.02.2013Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.03.2007
Opposition(s)18.02.2014No opposition filed within time limit [2014/17]
Fees paidRenewal fee
09.03.2005Renewal fee patent year 03
16.03.2006Renewal fee patent year 04
05.03.2007Renewal fee patent year 05
08.02.2008Renewal fee patent year 06
18.02.2009Renewal fee patent year 07
03.03.2010Renewal fee patent year 08
25.02.2011Renewal fee patent year 09
09.03.2012Renewal fee patent year 10
29.03.2013Renewal fee patent year 11
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO0156593  (LEUVEN RES AND DEV V Z W [BE], et al) [A] 1-18* claims *;
 [X]  - MAGLIONE D ET AL, "RECOMBINANT PRODUCTION OF PIGF-1 AND ITS ACTIVITY IN ANIMAL MODELS", FARMACO, SOCIETA CHIMICA ITALIANA, PAVIA, IT, (2000), vol. 55, ISSN 0014-827X, pages 165 - 167, XP001000056 [X] 1,6,8,13-18 * part 2.1 "Production and purification of the PIGF-1 protein";; figures 1,2 *

DOI:   http://dx.doi.org/10.1016/S0014-827X(00)00012-4
 [X]  - ZICHE M ET AL, "PLACENTA GROWTH FACTOR-1 IS CHEMOTACTIC, MITOGENIC, AND ANGIOGENIC", LABORATORY INVESTIGATION, UNITED STATES AND CANADIAN ACADEMY OF PATHOLOGY, BALTIMORE,, US, (199704), vol. 76, no. 4, ISSN 0023-6837, pages 517 - 531, XP001070886 [X] 6,8,13-18 * part "PIGF-1 Production and Purification"; page 518, column R, paragraph 3 - page 521, column L, paragraph 1; figures 1-3; table 1 *
ExaminationWO9206194
by applicantWO9206194
 EP0550519
 WO0156593
    - MAGLIONE, IL FARMACO, (2000), vol. 55, pages 165 - 167
    - LASTLY, FAILLE ET AL., JOURNAL INVEST. DERMATOL., (200009), vol. 115, no. 3, pages 388 - 395
    - ZICHE ET AL., "PLGF-1 is Chemotectic Mitogenic ad Angiogenic", LABORATORY INVESTIGATION, (199704), vol. 76, no. 4, pages 517 - 531
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.